Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

SARS-CoV-2 Omicron has similar infectious viral load to Delta

Researchers compare SARS-CoV-2 pre-variants of concern strains to the Delta and Omicron VOCs.

16 Jan 2022

Research shows fewer deaths related to COVID-19 in Cape Town during fourth wave

Researchers observe changes in COVID-19-related deaths during the fourth wave of the COVID-19 pandemic in South Africa.

16 Jan 2022

Asymptomatic COVID-19 patients less infectious than symptomatic patients

Researchers investigate the progression of infection in students and employees who tested positive for SARS-CoV-2 at Boston University.

16 Jan 2022

With no end in sight to pandemic life, parents find disruption is the new normal

As my kindergartner fumbled with his shoes, I stood at our door sifting through the mental parenting checklist newly lodged in my brain: backpack. Sweatshirt. Snacks. Sunscreen. Water bottle. KN95 mask. Vaccination card.

15 Jan 2022

As omicron surges, effort to vaccinate young children stalls

Two months after Pfizer's covid vaccine was authorized for children ages 5 to 11, just 27% have received at least one shot, according to Jan. 12 data from the Centers for Disease Control and Prevention. Only 18%, or 5 million kids, have both doses.

15 Jan 2022

Exploring the relationship between stem cells and COVID-19

Though COVID-19-related stem cell clinical research is still in its infancy, stem cell treatment offers extensive clinical application possibilities and a far-reaching relevance thanks to ongoing exploration of stem cell clinical research and data mining.

14 Jan 2022

Naïve T cells suggested as critical to low mortality of children with COVID-19

A new study discusses how naïve T cells may contribute to lower mortality rates seen in children with COVID-19.

14 Jan 2022

Exploring waning vaccine effectiveness over time

New research provides strong evidence against waning protection against symptomatic disease from both ChAdOx1-S and BNT162b2, but points out that protection against hospitalization and death remains at much higher levels for at least 20 weeks post-vaccination.

14 Jan 2022

Omicron variant spike protein shows significantly weaker membrane fusion activity than other variants

New research suggests that the SARS-CoV-2 Omicron spike protein requires significantly higher levels of ACE2 for efficient membrane fusion, lagging behind other variants.

14 Jan 2022

How has COVID-19 Impacted our Economy?

In this interview, News-Medical talks to Professor Adam Rose and his research team about how direct behavioral responses to COVID-19 have impacted the US economy.

14 Jan 2022

Study shows possible reverse zoonoses of SARS-CoV-2 from humans to animals

A new study describes an instance of natural infection of SARS-CoV-2 in a puma during the first wave and three lions during the third wave in a private zoo in South Africa in at least three transmission events from their handlers.

14 Jan 2022

Study reveals factors responsible for increased risk of aerosol transmission for SARS-CoV-2 Delta and Omicron

A new study describes the expected distribution of viral emission of COVID-19 by an infected population of people who were either silent, speaking softly, or loudly, to determine factors influencing risks of viral transmission.

14 Jan 2022

Synthetic antibody demonstrates Omicron detection along with all other variants of concern

MIP Diagnostics Ltd. has today announced that its synthetic SARS-CoV-2 antibody (COVID-19 nanoMIPTM) can detect the Omicron variant as well as previously proven Alpha, Beta, Delta and Gamma variants of the COVID-19 virus.

14 Jan 2022

Similarities and dissimilarities in immune responses and metabolism in SARS-CoV-2 and HIV-1 infections

A new study, posted to the bioRxiv* preprint server, has developed a single-cell atlas that presents the shared and distinct immune responses and metabolism following SARS-CoV-2 and HIV-1 infections.

13 Jan 2022

BNT162b2 COVID vaccine 94% effective against adolescent hospitalization

A recent study revealed the effectiveness of 93% for the BNT162b2 vaccine against COVID-19 hospitalization among adolescents (12 to 18 years). This study included 179 patients at 19 sites in 16 states. The same group of researchers have extended their analysis to 31 locations in 23 states across the U.S. and recruited 266 more patients who had been hospitalized with SARS-CoV-2 infection.

13 Jan 2022

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

SARS-CoV-2 Omicron has similar infectious viral load to Delta

Research shows fewer deaths related to COVID-19 in Cape Town during fourth wave

Asymptomatic COVID-19 patients less infectious than symptomatic patients

With no end in sight to pandemic life, parents find disruption is the new normal

As omicron surges, effort to vaccinate young children stalls

Exploring the relationship between stem cells and COVID-19

Naïve T cells suggested as critical to low mortality of children with COVID-19

Exploring waning vaccine effectiveness over time

Omicron variant spike protein shows significantly weaker membrane fusion activity than other variants

How has COVID-19 Impacted our Economy?

Study shows possible reverse zoonoses of SARS-CoV-2 from humans to animals

Study reveals factors responsible for increased risk of aerosol transmission for SARS-CoV-2 Delta and Omicron

Synthetic antibody demonstrates Omicron detection along with all other variants of concern

Similarities and dissimilarities in immune responses and metabolism in SARS-CoV-2 and HIV-1 infections

BNT162b2 COVID vaccine 94% effective against adolescent hospitalization

COVID-19 vaccination breakthrough infections in a real-world setting

Specific immunoresponse to SARS-CoV-2 in cats and dogs housed with COVID-19 patients

Insignificant homology of SARS-CoV-2 spike sequences to myocarditis-associated antigens

Hollow fiber membranes efficiently remove synthetic SARS-CoV-2 from the air

Researchers identify gene variant that protects against severe COVID-19

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in